| PTLE 0.282 51.53% | SOXS 3.65 11.56% | MSPR 0.664 27.57% | SCNX 0.8182 15.35% | NVDA 198.69 -3.96% | SQQQ 13.79 6.16% | ORIS 0.1603 -0.12% | BYND 1.33 -4.32% | PFE 24.3 -1.46% | HTZ 6.73 36.23% | PLTR 190.74 -7.94% | TSLL 20.34 -10.16% | ETHA 24.28 -10.37% | ASST 1.25 -1.57% | IBIT 57.18 -5.53% | GRAB 5.785 -4.70% | INTC 37.03 -6.25% | PLUG 2.52 -8.36% | ONDS 5.96 -3.09% | OPEN 6.92 -8.83% | CHR 0.136 8.11% | FGL 0.5165 26.94% | DNN 2.74 -6.00% | TSLA 444.26 -5.15% | WTO 0.0497 -6.23% | CAPT 0.6615 31.77% | NFE 1.35 14.41% | SOXL 42.8 -11.90% | BITF 3.84 -6.57% | ETHD 5.26 20.92% | T 24.44 -0.37% | EPWK 0.0748 3.60% | F 12.79 -1.69% | SPY 675.24 -1.19% | SOFI 29.37 -4.11% | KVUE 15.97 -1.05% | ACHR 9.56 -8.25% | CIFR 22.51 -1.10% | QQQ 619.25 -2.03% | HIMS 42.79 -3.60% | GPUS 0.3494 -7.03% | TQQQ 111.08 -6.12% | LQD 110.68 0.14% | BTBT 3.18 -7.02% | AAL 12.65 -5.17% | TZA 8.21 5.26% | BURU 0.29 -7.91% | NCLH 18.79 -15.28% | RGTI 35.18 -10.07% | BTG 4 -5.77%

Silvergate Capital Corporation's Public Debut

Silvergate Capital Corporation, trading under the symbol SI on the NYSE, is making its public debut by offering 5 million shares at $15 each. This move marks a significant milestone for the company as it seeks to attract investors and expand its market presence. Silvergate Capital is known for its focus on providing financial infrastructure solutions and services to the digital currency industry.

Currently, SI's stock is priced at $14.25, reflecting a decrease of 5.32% or $0.80. The stock has shown volatility, with today's trading range between $13.05 and $14.88. Over the past year, SI reached a high of $17.94 and a low of $13.05. The company's market capitalization is approximately $283.9 million, with a trading volume of 454,007 shares.

In comparison, Shoulder Innovations' IPO was priced below expectations due to a slowdown in revenue growth. Despite a modest valuation of three to four times its sales and a strong net cash position, the company faces challenges such as ongoing operating losses and competition from established medical technology giants like J&J and Stryker.

While Silvergate Capital's IPO pricing appears stable, the stock's recent performance indicates investor caution. The decrease in stock price and its fluctuation suggest that investors are closely monitoring the company's financial health and market conditions. As Silvergate Capital navigates its public offering, it will need to address these concerns to maintain investor confidence.

Published on: August 1, 2025